collecting site positivity data in region i andee krasner, mph region i ipp advisory board meeting

8
Collecting Site Positivity Data in Region I Andee Krasner, MPH Region I IPP Advisory Board Meeting

Upload: bertina-andrews

Post on 03-Jan-2016

213 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Collecting Site Positivity Data in Region I Andee Krasner, MPH Region I IPP Advisory Board Meeting

Collecting Site Positivity Data in Region I

Andee Krasner, MPHRegion I IPP Advisory Board Meeting

Page 2: Collecting Site Positivity Data in Region I Andee Krasner, MPH Region I IPP Advisory Board Meeting

Background

• In 2006, Region I began collecting only IPP-funded CT testing data

• In 2010, CDC requested that the Infrastructure begin process of collecting site CT data, not just IPP-funded CT Testing

2

Page 3: Collecting Site Positivity Data in Region I Andee Krasner, MPH Region I IPP Advisory Board Meeting

Goals

• With minimum burden to IPP AB Members, collect site positivity for IPP-funded sites and report to CDC

• Make site positivity data available through state IPP Prevalence Monitoring System for use at state and local level

3

Page 4: Collecting Site Positivity Data in Region I Andee Krasner, MPH Region I IPP Advisory Board Meeting

CSPS- 3% Minimum

• CSPS guidance assumes site positivity, not IPP positivity

• Not known how IPP positivity rates compare to site positivity

• If you have site positivity data, you should use it to determine 3% minimum positivity requirements for CSPS

• May use IPP positivity rates for CSPS until site positivity project is complete

4

Page 5: Collecting Site Positivity Data in Region I Andee Krasner, MPH Region I IPP Advisory Board Meeting

Plan for Collecting Site Positivity

• Work with State STD Directors and Lab Directors to request data extracts for data already collected by the state

• Work with STD Directors and Family Planning Directors to request data from private labs

• Develop systems for feeding site positivity data back into Prevalence Monitoring Data Systems

5

Page 6: Collecting Site Positivity Data in Region I Andee Krasner, MPH Region I IPP Advisory Board Meeting

Requested Data Fields• Request limited dataset from Labs:

• Medical Record # / (Lab ID # will be ok)

• Test Facility ID

• State of Client residence (zip is ok)

• Age (DOB is ok)

• Gender

• Test for CT and/or GC

• Test result

• Date of test performed

• Nice to have:• Race/Ethnicity

• Clinical History (source, pregnant, routine exam)

• Payment

• Risk History6

Page 7: Collecting Site Positivity Data in Region I Andee Krasner, MPH Region I IPP Advisory Board Meeting

Progress

• RI – provided data extract for all tests from IPP sites

• PPNNE – provided data extract from all PPNNE IPP sites in VT, NH and ME

• NH State Lab going to an electronic reporting system. They will provide extract of all state-funded tests at IPP sites.

7

Page 8: Collecting Site Positivity Data in Region I Andee Krasner, MPH Region I IPP Advisory Board Meeting

Next Steps

• Non-IPP funded tests received– Develop a system for feeding data back into state

Prevalence Monitoring System

• Work with AB Members to request limited dataset from IPP sites1.New Hampshire

2.Maine

3.Connecticut

4.Massachusetts

8